Profile
ProfileHighlightsBusinessActivitiesPublicationsNews

History 
Founders 
Technologies 
BMSystems>Profile

 

Mission Statement

  • Our company elaborates comprehensive biological models aiming to improve the success-rate of the Drug Development process an dthe white biotech processes. The outputs of our proprietary models allow to:
    1. Increase the commercial value of a existing drugs Portfolio by enhancing therapeutic potentials while diversifying domains of applications.
    2. Rescue molecules encountering serious difficulties in late development phases.
    3. Accelerate the identification and validation of physiologically coherent targets and pharmacological interventions.
    4. Accelerate and streamline regulatory processes by addressing key issues such as mechanisms of drug action, drug interactions potential, exclusion criteria, etc….
    5. Find and validate new biological processes in the field of white Biotech

Bio-Modeling Systems is an independent entity specialised in Predictive Integrative Biology. Incorporated in 2004 and fully owned by its founders, BMSystems is, to date, the only commercially active Predictive Integrative Biology company that:

  1. Has already produced eleven semi-quantitative in-silico predictive integrated physiological models of complex human pathologies.
  2. Has already independently experimentally tested five of them and validated five four.
  3. Has already published two in peer reviewed scientific journals (Nucleic Acids Research and the Journal of Molecular Endocrinology) and is preparing publication of another two,
  4. Has Developed an innovative deal structure to accelerate & simplify industrial business partnerships.
  5. Is currently contractually collaborating with Big Pharma in major domains of drugs and targets therapeutic applications on this innovative approach, and,
  6. Provides clear industrial competitive advantages to  its industrial business partners.
  7. Already launched its first spin-off (Pherecydes Pharma: antibacterial biological agent) in the field of bio-defense &bio-security.

Corporate profile

  • Bio-Modeling Systems SAS
  • Private company
  • Equity: 350k€
  • 100% owned by its founders
  • Founders : 7
  • Direct access to large worldwide experts networks.

Accueil | Profile | Highlights | Business | Activities | Publications | News

Copyright © 2003 Bio-Modeling Systems / BMSystems. All rights reserved
bmsystems@bmsystems.net